Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Dioscorea collettii has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Saponin-rich Dioscorea extracts partition into fat rather than water. A lipid-soluble companion nutrient rides the same mixed-micelle route across the intestinal wall, so the two are commonly formulated together in an oil base. This is a formulation rationale drawn from solubility chemistry. No human study has compared the pairing against the extract alone.
Piperine is an established inhibitor of glucuronidation and CYP3A4 in the gut wall. Saponins and their sapogenin aglycones are cleared partly by those routes, so co-dosing would be expected to raise systemic exposure. The mechanism is well described in general pharmacology. It has not been measured for this particular herb, and a higher exposure is not automatically a better outcome.
The glycoside form of a steroidal saponin is poorly absorbed intact. Removal of the sugar moiety by intestinal and bacterial glycosidases releases the smaller aglycone, which crosses the enterocyte far more readily. This is settled glycoside pharmacology and explains why absorption varies so much between people with different gut flora. Whether an added enzyme blend measurably changes that has not been tested here.
Conversion of plant glycosides to their absorbable aglycones is largely a bacterial job in the colon. People with different flora generate different amounts of the active species from the same dose. That makes the microbiome a plausible determinant of response to Dioscorea saponins. It also means any measured effect is a marker of conversion capacity, not a demonstrated clinical benefit of the pairing.
Preclinical work on both plants points at the same downstream signalling nodes, NF-kappaB among them. Stacking two botanicals that converge on one pathway is a common formulation choice. The supporting data are cell and animal work, not human trials of the combination. Read it as mechanistic rather than clinical.
Nothing specific on file for Dioscorea collettii. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Dioscorea collettii. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.